Mark James Litton's Net Worth
$5.83 Million
Who is Mark James Litton?
Mark James Litton has an estimated net worth of $5.83 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, ALPINE IMMUNE SCIENCES, INC., and Athira Pharma, Inc..
SEC CIK
Mark James Litton's CIK is 0001604834
Past Insider Trading and Trends
2017 was Mark James Litton's most active year for acquiring shares with 7 total transactions. Mark James Litton's most active month to acquire stocks was the month of December. 2016 was Mark James Litton's most active year for disposing of shares, totalling 16 transactions. Mark James Litton's most active month to dispose stocks was the month of December. 2021 saw Mark James Litton paying a total of $91,693.50 for 137,192 shares, this is the most they've acquired in one year. In 2015 Mark James Litton cashed out on 92,764 shares for a total of $2,148,960.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$9.41 | -$382,911.89 | 102.19K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$6.23 | -$151,229.79 | 99.93K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$6.99 | -$176,445.16 | 99.93K |
Scheduled
|
Oct 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
$12.38 | -$32,127.01 | 99.93K |
Scheduled
|
Jan 18
| ||
Form 4
| -1.00% | -1.00K |
$11.64 | -$207,901.14 | 99.93K |
Scheduled
|
Jan 5 - Jan 9
| ||
Form 4
| -7.14% | -6.00K |
$27.50 | -$164,997.80 | 78K |
Scheduled
|
Oct 17
| ||
Form 4
| +33.53% | 25K |
$0.39 | $9,625.00 | 99.57K |
Jul 12
| |||
Form 4
| -6.67% | -6.00K |
$28.94 | -$173,663.53 | 84K |
Scheduled
|
Jun 13
| ||
Form 4
|
—
|
0
|
$15.22 | -$741,634.32 | 74.57K |
Scheduled
|
May 27 - May 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
$15.90 | -$775,326.42 | 73.72K |
Scheduled
|
Jan 4
| ||
Form 4
| -9.33% | -7.50K |
$32.27 | -$242,002.29 | 72.92K |
Scheduled
|
Oct 1
| ||
Form 4
| +18.87% | 12.76K |
$1.27 | $16,146.46 | 80.42K |
Sep 24
| |||
Form 4
| -9.98% | -7.50K |
$51.10 | -$383,219.25 | 67.66K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$22.33 | -$1,097,227.50 | 75.16K |
Jun 4
| |||
Form 4
| -9.16% | -7.50K |
$27.41 | -$205,552.50 | 74.36K |
Scheduled
|
Apr 1
| ||
Form 4
| -8.39% | -7.50K |
$28.18 | -$211,334.29 | 81.86K |
Scheduled
|
Jan 26 - Jan 27
| ||
Form 4
| -25.32% | -30.00K |
$15.63 | -$469,011.00 | 88.48K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.1
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Athira Pharma, Inc. (ATHA) Snapshot price: $3.08
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4/A
| +11.75% | 15.18K |
$2.91 | -$14,026.20 | 144.4K |
Jan 4 - Jan 5
| |||
Form 4
| +11.75% | 15.18K |
$2.91 | -$14,026.20 | 144.4K |
Jan 4 - Jan 5
| |||
Form 4
| +0.51% | 662 |
$2.74 | $1,813.88 | 129.22K |
Nov 18 - Jan 27
| |||
Form 4
| +11.05% | 12.8K |
$4.88 | -$16,067.98 | 128.56K |
May 18 - Jun 23
| |||
Form 4
| +0.77% | 885 |
$12.51 | $11,071.35 | 115.76K |
Nov 18 - Jan 27
| |||
Form 4
| +80.71% | 51.31K |
$1.57 | $80,622.15 | 114.87K |
May 18 - Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +65.06% | 32.81K |
—
|
—
| 83.25K |
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||